ICT-107
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ICT-107, covering 2014-10-07 to 2024-04-03. Get the full timeline:
Most recent: Clinical Trial Update: Phase 3 Randomized, Double-blind, Controlled Study of ICT-107 in Glioblastoma [Phase 3]